Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
The novel ATR inhibitor VE-821...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy
Bibliographic Details
Main Authors:
Fokas, E
,
Prevo, R
,
Reaper, P
,
Charlton, P
,
Pollard, J
,
Mckenna, W
,
Muschel, R
,
Brunner, T
Format:
Conference item
Published:
2012
Holdings
Description
Similar Items
Staff View
Similar Items
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.
by: Prevo, R, et al.
Published: (2012)
ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
by: Fokas, E, et al.
Published: (2013)
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
by: Fokas, E, et al.
Published: (2012)
Targeting ATR in DNA damage response and cancer therapeutics.
by: Fokas, E, et al.
Published: (2014)
Targeting ATR in DNA damage response and cancer therapeutics
by: Fokas, E, et al.
Published: (2014)